DEVELOPMENT OF METABOLIC SYNDROME AT PERSONS OF REPRODUCTIVE AGE
https://doi.org/10.29235/1814-6023-2018-15-1-76-83
Abstract
The aim of the work was to study the development of the metabolic syndrome signs of persons of reproductive age. 217 people aged 18–44 were examined, 156 women and 61 men. There were significant differences between subgroups of women and men: higher blood pressure, body mass index, triglycerides, AST, ALT and bilirubin in men than in women. In the general group of subjects with abdominal obesity there were 28.1 % (33.3 % among men and 26.1 % among women). Elevated blood pressure was noted in 20.7 % of individuals (38.3 % in men and 14.0 % in women). Metabolic syndrome was detected in 10.1 % of individuals (11.7 % in men and 9.6 % in women). In the group of people with abdominal obesity, high blood pressure was noted in 44.3 % of individuals (45.0 % in men and 43.9 % in women). Metabolic syndrome was registered in 36.1 % of individuals (35.0 % in men and 36.5 % in women). In the group of persons without abdominal obesity, only 11.5 % of the examined patients had an elevated blood pressure. The frequency of this sign significantly prevailed in men (35.0 %) compared with women (3.4 %). Thus, young slender men had an increased risk of developing hypertension compared with women of a similar constitution and age.
About the Authors
Tatyana A. Mityukova
Institute of Physiology of the National Academy of Sciences of Belarus
Belarus
Belarus
Ph. D. (Biol.), Leading researcher
28, Akademicheskaya Str., 220072, Minsk
Svetlana B. Kohan
Institute of Physiology of the National Academy of Sciences of Belarus
Belarus
Belarus
Researcher
28, Akademicheskaya Str., 220072, Minsk
Evgenia B. Luzina
Institute of Physiology of the National Academy of Sciences of Belarus
Belarus
Belarus
Junior researcher
28, Akademicheskaya Str., 220072, Minsk
Olga E. Polulyach
Institute of Physiology of the National Academy of Sciences of Belarus
Belarus
Belarus
Researcher
28, Akademicheskaya Str., 220072, Minsk
References
1. Alberti K. G., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., Fruchart J. C., James W. P., Loria C. M., Smith S. C. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009, vol. 120, no. 16, pp. 1640–1645. DOI: 10.1161/CIRCULATIONAHA.109.192644
2. Kolovou G. D., Anagnostopoulou K. K., Salpea K. D., Mikhailidis D. P. The prevalence of metabolic syndrome in various populations. American Journal of the Medical Sciences, 2007, vol. 333, no. 6, pp. 362–371. DOI: 10.1097/MAJ.0b013e318065c3a1
3. World Report on Agening and Health. Luxembourg, World Health Organization Publ., 2015. 247 p.
4. Cameron A. J., Shaw J. E., Zimmet P. Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinology and Metabolism Clinics of North America, 2004, vol. 33, no. 2, pp. 351–375. DOI: 10.1016/j.ecl.2004.03.005
5. Park Y. W., Zhu S., Palaniappan L., Heshka S., Carnethon M. R., Heymsfield S. B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Archives of Internal Medicine, 2003, vol. 163, no. 4, pp. 427–436. DOI: 10.1001/archinte.163.4.427
6. Wilson P. W. F., Kannel W. B., Silbershatz H., D’Agostino R. B. Clustering of metabolic factors and coronary heart disease. Archives of Internal Medicine, 1999, vol. 159, no. 10, pp. 1104–1109. DOI: 10.1001/archinte.159.10.1104
7. Palaniappan L., Carnethon M. R., Wang Y., Hanley A. J. G., Fortmann S. P., Haffner S. M., Wagenknecht L. Predictors of the incident metabolic syndrome in adults: the insulin resistance atherosclerosis study. Diabetes Care, 2004, vol. 27, no. 3, pp. 788–793. DOI: 10.2337/diacare.27.3.788
8. Ponholzer A., Temml C., Rauchenwald M., Marszalek M., Madersbacher S. Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women? International Journal of Impotence Research, 2008, vol. 20, no. 1, pp. 100–104. DOI: 10.1038/sj.ijir.3901605
9. Shliakhto E. V., Konradi A. O. E. V. Epidemiology of metabolic syndrome in different regions. Dependence on the criteria used and practical value. Arterial’naya gipertenziya [Arterial hypertension], 2007, vol. 13, no. 2, pp. 95–112 (in Russian).
10. Tokareva Z. N. The prevalence and features of metabolic syndrome in the adult population of the city of Cheboksary. Abstract of Ph. D. diss. Moscow, 2010. 25 p. (in Russian).
11. Mityukova T. A., Lushchik M. L., Okulevich N. M., Leonova T. A., Platonova T. Yu., Drozd V. M. The influence of thyroid status on the development of metabolic syndrome in persons of reproductive age. Vestsі Natsyianal’nai akademіі navuk Belarusі. Seryia medytsynskіkh navuk = Proceedings of the National Academy of Sciences of Belarus. Medicine series, 2013, no. 2, pp. 57–65 (in Russian).
Review
For citations:
Mityukova T.A., Kohan S.B., Luzina E.B., Polulyach O.E. DEVELOPMENT OF METABOLIC SYNDROME AT PERSONS OF REPRODUCTIVE AGE. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2018;15(1):76-83. (In Russ.) https://doi.org/10.29235/1814-6023-2018-15-1-76-83
Views: 569
Email this article 